29/04/2015 - 19:53 MANCHESTER, ENGLAND – Results of the Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Rheumatoid Arthritis... More » Visit websiteField of Interest: RheumatologyCategories: CME-candidateCARD || Conference NewsFPN || ConferencesIMN || ConferencesRHEUM || Conference NewsCARD || NewsCARD || CAD & AtherosclerosisCARD || Epidemiology & PreventionFPN || NewsNews Feed: Internal Medicine News - Rheumatology